- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Diabetes Research
Volume 2013 (2013), Article ID 737485, 10 pages
The Missing Heritability in T1D and Potential New Targets for Prevention
1Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA
2Department of Microbiology and Immunology, Center for Immunogenetics and Inflammatory Diseases, Drexel University College of Medicine, Philadelphia, PA 19129, USA
3Children’s Hospital Oakland Research Institute, Oakland, CA 94609, USA
4Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA
Received 7 January 2013; Accepted 13 February 2013
Academic Editor: Norihide Yokoi
Copyright © 2013 Brian G. Pierce et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- T. L. Van Belle, K. T. Coppieters, and M. G. Von Herrath, “Type 1 diabetes: etiology, immunology, and therapeutic strategies,” Physiological Reviews, vol. 91, no. 1, pp. 79–118, 2011.
- J. E. Tooley, F. Waldron-Lynch, and K. C. Herold, “New and future immunomodulatory therapy in type 1 diabetes,” Trends in Molecular Medicine, vol. 18, no. 3, pp. 173–181, 2012.
- C. Polychronakos and Q. Li, “Understanding type 1 diabetes through genetics: advances and prospects,” Nature Reviews Genetics, vol. 12, no. 11, pp. 781–792, 2011.
- M. Trucco, “Gene-environment interaction in type 1 diabetes mellitus,” Endocrinología y Nutrición, vol. 56, no. 4, pp. 56–59, 2009.
- D. K. Wherrett and D. Daneman, “Prevention of type 1 diabetes,” Endocrinology and Metabolism Clinics of North America, vol. 38, no. 4, pp. 777–790, 2009.
- A. W. Michels and G. S. Eisenbarth, “Immune intervention in type 1 diabetes,” Seminars in Immunology, vol. 23, no. 3, pp. 214–219, 2011.
- L. Zhang and G. S. Eisenbarth, “Prediction and prevention of Type 1 diabetes mellitus,” Journal of Diabetes, vol. 3, no. 1, pp. 48–57, 2011.
- H. Erlich, A. M. Valdes, J. Noble et al., “HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk analysis of the type 1 diabetes genetics consortium families,” Diabetes, vol. 57, no. 4, pp. 1084–1092, 2008.
- A. Ide, S. R. Babu, D. T. Robles et al., ““Extended” A1, B8, DR3 haplotype shows remarkable linkage disequilibrium but is similar to nonextended haplotypes in terms of diabetes risk,” Diabetes, vol. 54, no. 6, pp. 1879–1883, 2005.
- J. A. Noble, A. M. Valdes, M. D. Varney et al., “HLA class I and genetic susceptibility to type 1 diabetes: results from the type 1 diabetes genetics consortium,” Diabetes, vol. 59, no. 11, pp. 2972–2979, 2010.
- P. Concannon, S. S. Rich, and G. T. Nepom, “Genetics of type 1A diabetes,” New England Journal of Medicine, vol. 360, no. 16, pp. 1646–1654, 2009.
- D. J. Smyth, V. Plagnol, N. M. Walker et al., “Shared and distinct genetic variants in type 1 diabetes and celiac disease,” New England Journal of Medicine, vol. 359, no. 26, pp. 2767–2777, 2008.
- M. Rewers, T. L. Bugawan, J. M. Norris et al., “Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY),” Diabetologia, vol. 39, no. 7, pp. 807–812, 1996.
- J. L. Davies, Y. Kawaguchi, S. T. Bennett et al., “A genome-wide search for human type 1 diabetes susceptibility genes,” Nature, vol. 371, no. 6493, pp. 130–136, 1994.
- D. G. Clayton, “Prediction and interaction in complex disease genetics: experience in type 1 diabetes,” PLoS Genetics, vol. 5, no. 7, Article ID e1000540, 2009.
- C. Winkler, J. Krumsiek, J. Lempainen, et al., “A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes,” Genes & Immunity, vol. 13, no. 7, pp. 549–555, 2012.
- Z. Liu, L. Cort, R. Eberwine, et al., “Prevention of type 1 diabetes in the rat with an allele-specific anti-T cell receptor antibody: Vβ13 as a therapeutic target and biomarker,” Diabetes, vol. 61, no. 5, pp. 1160–1168, 2012.
- J. P. Mordes, L. Cort, E. Norowski et al., “Analysis of the rat Iddm14 diabetes susceptibility locus in multiple rat strains: identification of a susceptibility haplotype in the Tcrb-V locus,” Mammalian Genome, vol. 20, no. 3, pp. 162–169, 2009.
- K. E. Ellerman and A. A. Like, “Susceptibility to diabetes is widely distributed in normal class II(u) haplotype rats,” Diabetologia, vol. 43, no. 7, pp. 890–898, 2000.
- M. Stienekemeier, K. Hofmann, R. Gold, and T. Herrmann, “A polymorphism of the rat T-cell receptor β-chain variable gene 13 (BV13S1) correlates with the frequency of BV13S1-positive CD4 cells,” Immunogenetics, vol. 51, no. 4-5, pp. 296–305, 2000.
- Z. Laron, “Interplay between heredity and environment in the recent explosion of type 1 childhood diabetes mellitus,” American Journal of Medical Genetics, vol. 115, no. 1, pp. 4–7, 2002.
- A. Green and C. C. Patterson, “Trends in the incidence of childhood-onset diabetes in Europe 1989–1998,” Diabetologia, vol. 44, no. 3, pp. B3–B8, 2001.
- T. H. Lipman, Y. Chang, and K. M. Murphy, “The epidemiology of type 1 diabetes in children in Philadelphia 1990–1994: evidence of an epidemic,” Diabetes Care, vol. 25, no. 11, pp. 1969–1975, 2002.
- N. van der Werf, F. G. M. Kroese, J. Rozing, and J. L. Hillebrands, “Viral infections as potential triggers of type 1 diabetes,” Diabetes/Metabolism Research and Reviews, vol. 23, no. 3, pp. 169–183, 2007.
- C. T. Watson, A. E. Para, M. R. Lincoln et al., “Revisiting the T-cell receptor alpha/delta locus and possible associations with multiple sclerosis,” Genes and Immunity, vol. 12, no. 2, pp. 59–66, 2011.
- S. J. Manavalan, J. R. Valiando, W. H. Reeves et al., “Genomic Absence of the Gene Encoding T Cell Receptor Vβ7.2 Is Linked to the Presence of Autoantibodies in Sjögren's Syndrome,” Arthritis and Rheumatism, vol. 50, no. 1, pp. 187–198, 2004.
- R. A. Kay, C. J. Hutchings, and W. E. R. Ollier, “A subset of Sjogren's syndrome associates with the TCRBV13S2 locus but not the TCRBV2S1 locus,” Human Immunology, vol. 42, no. 4, pp. 328–330, 1995.
- J. L. Black, “Narcolepsy: a review of evidence for autoimmune diathesis,” International Review of Psychiatry, vol. 17, no. 6, pp. 461–469, 2005.
- J. Hallmayer, J. Faraco, L. Lin, et al., “Narcolepsy is strongly associated with the T-cell receptor alpha locus,” Nature Genetics, vol. 41, no. 6, pp. 708–711, 2009.
- T. Miyagawa, M. Honda, M. Kawashima et al., “Polymorphism located in TCRA locus confers susceptibility to essential hypersomnia with HLA-DRB1*1501-DQB1*0602 haplotype,” Journal of Human Genetics, vol. 55, no. 1, pp. 63–65, 2010.
- J. P. Mordes, P. Poussier, A. A. Rossini, E. P. Blankenhorn, and D. L. Greiner, “Rat models of type 1 diabetes: Genetics, environment, and autoimmunity,” in Animal Models of Diabetes: Frontiers in Research, E. Shafrir, Ed., pp. 1–39, 2007.
- T. Awata, D. L. Guberski, and A. A. Like, “Genetics of the BB rat: association of autoimmune disorders (diabetes, insulitis, and thyroiditis) with lymphopenia and major histocompatibility complex class II,” Endocrinology, vol. 136, no. 12, pp. 5731–5735, 1995.
- A. M. Martin, M. N. Maxson, J. Leif, J. P. Mordes, D. L. Greiner, and E. P. Blankenhorn, “Diabetes-prone and diabetes-resistant BB rats share a common major diabetes susceptibility locus, iddm4: additional evidence for a “universal autoimmunity locus” on rat chromosome 4,” Diabetes, vol. 48, no. 11, pp. 2138–2144, 1999.
- E. P. Blankenhorn, L. Rodemich, C. Martin-Fernandez, J. Leif, D. L. Greiner, and J. P. Mordes, “The rat diabetes susceptibility locus iddm4 and at least one additional gene are required for autoimmune diabetes induced by viral infection,” Diabetes, vol. 54, no. 4, pp. 1233–1237, 2005.
- J. P. Mordes, J. Leif, S. Novak, C. Descipio, D. L. Greiner, and E. P. Blankenhorn, “The iddm4 locus segregates with diabetes susceptibility in congenic WF.iddm4 Rats,” Diabetes, vol. 51, no. 11, pp. 3254–3262, 2002.
- L. Hornum, C. DeScipio, H. Markholst et al., “Comparative mapping of rat iddm4 to segments on HSA7 and MMU6,” Mammalian Genome, vol. 15, no. 1, pp. 53–61, 2004.
- E. P. Blankenhorn, C. Descipio, L. Rodemich et al., “Refinement of the iddm4 diabetes susceptibility locus reveals TCRVβ4 as a candidate gene,” Annals of the New York Academy of Sciences, vol. 1103, pp. 128–131, 2007.
- J. M. Fuller, M. Bogdani, T. D. Tupling et al., “Genetic dissection reveals diabetes loci proximal to the gimap5 lymphopenia gene,” Physiological Genomics, vol. 38, no. 1, pp. 89–97, 2009.
- J. P. Mordes, D. L. Guberski, J. H. Leif et al., “LEW.1WR1 rats develop autoimmune diabetes spontaneously and in response to environmental perturbation,” Diabetes, vol. 54, no. 9, pp. 2727–2733, 2005.
- R. S. Tirabassi, D. L. Guberski, E. P. Blankenhorn et al., “Infection with viruses from several families triggers autoimmune diabetes in LEW.1WR1 rats: prevention of diabetes by maternal immunization,” Diabetes, vol. 59, no. 1, pp. 110–118, 2010.
- M. Nakayama, T. Castoe, T. Sosinowski, et al., “Germline TRAV5D-4 T cell receptor sequence targets a primary insulin peptide of NOD mice,” Diabetes, vol. 61, no. 4, pp. 857–865, 2012.
- L. Zhang, J. M. Jasinski, M. Kobayashi et al., “Analysis of T cell receptor beta chains that combine with dominant conserved TRAV5D-4*04 anti-insulin B:9-23 alpha chains,” Journal of Autoimmunity, vol. 33, no. 1, pp. 42–49, 2009.
- H. M. Berman, J. Westbrook, Z. Feng et al., “The protein data bank,” Nucleic Acids Research, vol. 28, no. 1, pp. 235–242, 2000.
- N. Abiru, D. Wegmann, E. Kawasaki, P. Gottlieb, E. Simone, and G. S. Eisenbarth, “Dual overlapping peptides recognized by insulin peptide B:9–23 T cell receptor AV13S3 T cell clones of the NOD mouse,” Journal of Autoimmunity, vol. 14, no. 3, pp. 231–237, 2000.
- K. W. Wucherpfennig, E. Gagnon, M. J. Call, E. S. Huseby, and M. E. Call, “Structural biology of the T-cell receptor: insights into receptor assembly, ligand recognition, and initiation of signaling,” Cold Spring Harbor Perspectives in Biology, vol. 2, no. 4, Article ID a005140, 2010.
- S. Ghosh, S. M. Palmer, N. R. Rodrigues et al., “Polygenic control of autoimmune diabetes in nonobese diabetic mice,” Nature Genetics, vol. 4, no. 4, pp. 404–409, 1993.
- E. A. Simone, L. Yu, D. R. Wegmann, and G. S. Eisenbarth, “T cell receptor gene polymorphisms associated with anti-insulin, autoimmune T cells in diabetes-prone NOD mice,” Journal of Autoimmunity, vol. 10, no. 3, pp. 317–321, 1997.
- K. W. Wucherpfennig, “The first structures of T cell receptors bound to peptide-MHC,” Journal of Immunology, vol. 185, no. 11, pp. 6391–6393, 2010.
- B. C. Sim, L. Zerva, M. I. Greene, and N. R. J. Gascoigne, “Control of MHC restriction by TCR V(α) CDR1 and CDR2,” Science, vol. 273, no. 5277, pp. 963–966, 1996.
- N. A. Borg, L. K. Ely, T. Beddoe et al., “The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition,” Nature Immunology, vol. 6, no. 2, pp. 171–180, 2005.
- J. J. Adams, S. Narayanan, B. Liu, et al., “T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex,” Immunity, vol. 35, no. 5, pp. 681–693, 2011.
- D. K. Sethi, D. A. Schubert, A. K. Anders et al., “A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHC,” Journal of Experimental Medicine, vol. 208, no. 1, pp. 91–102, 2011.
- S. E. Broughton, J. Petersen, A. Theodossis, et al., “Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease,” Immunity, vol. 37, no. 4, pp. 611–621, 2012.
- M. P. Lefranc, C. Pommié, M. Ruiz et al., “IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains,” Developmental and Comparative Immunology, vol. 27, no. 1, pp. 55–77, 2003.
- M. P. Lefranc, V. Giudicelli, C. Ginestoux et al., “IMGT, the international ImMunoGeneTics information system,” Nucleic Acids Research, vol. 37, no. 1, pp. D1006–D1012, 2009.
- R. Mackelprang, R. J. Livingston, M. A. Eberle et al., “Sequence diversity, natural selection and linkage disequilibrium in the human T cell receptor alpha/delta locus,” Human Genetics, vol. 119, no. 3, pp. 255–266, 2006.
- D. L. Altshuler, R. M. Durbin, G. R. Abecasis et al., “A map of human genome variation from population-scale sequencing,” Nature, vol. 467, no. 7319, pp. 1061–1073, 2010.
- L. R. Meyer, A. S. Zweig, A. S. Hinrichs, et al., “The UCSC genome browser database: extensions and updates 2013,” Nucleic Acids Research, vol. 41, no. 1, pp. D64–D69, 2012.
- Q. Kaas, E. Duprat, G. Tourneur, et al., “IMGT standardization for molecular characterization of the T-cell receptor/peptide/MHC complexes,” Immunoinformatics, vol. 1, pp. 19–49, 2008.
- B. G. Pierce and Z. Weng, “A flexible docking approach for prediction of T cell receptor-peptide-MHC complexes,” Protein Science, vol. 22, no. 1, pp. 35–46, 2012.
- S. Gras, Z. Chen, J. J. Miles et al., “Allelic polymorphism in the T cell receptor and its impact on immune responses,” Journal of Experimental Medicine, vol. 207, no. 7, pp. 1555–1567, 2010.
- J. Hennecke and D. C. Wiley, “Structure of a complex of the human α/β T cell receptor (TCR) HA1.7, Influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRBI*0401): insight into TCR cross-restriction and alloreactivity,” Journal of Experimental Medicine, vol. 195, no. 5, pp. 571–581, 2002.
- M. G. Rudolph, R. L. Stanfield, and I. A. Wilson, “How TCRs bind MHCs, peptides, and coreceptors,” Annual Review of Immunology, vol. 24, pp. 419–466, 2006.
- B. Moza, R. A. Buonpane, P. Zhu et al., “Long-range cooperative binding effects in a T cell receptor variable domain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 26, pp. 9867–9872, 2006.
- B. G. Pierce, J. N. Haidar, Y. Yu, and Z. Weng, “Combinations of affinity-enhancing mutations in a T cell receptor reveal highly nonadditive effects within and between complementarity determining regions and chains,” Biochemistry, vol. 49, no. 33, pp. 7050–7059, 2010.
- W. F. Hawse, M. M. Champion, M. V. Joyce, et al., “Cutting edge: evidence for a dynamically driven T cell signaling mechanism,” Journal of Immunology, vol. 188, no. 12, pp. 5819–5823, 2012.
- G. R. Abecasis, A. Auton, L. D. Brooks, et al., “An integrated map of genetic variation from 1,092 human genomes,” Nature, vol. 491, no. 7422, pp. 56–65, 2012.
- A. W. Michels and M. Nakayama, “The anti-insulin trimolecular complex in type 1 diabetes,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 17, no. 4, pp. 329–334, 2010.
- J. Faraco and E. Mignot, “Immunological and genetic aspects of narcolepsy,” Sleep Medicine Research, vol. 2, pp. 1–9, 2011.
- S. T. Sherry, M. H. Ward, M. Kholodov et al., “DbSNP: the NCBI database of genetic variation,” Nucleic Acids Research, vol. 29, no. 1, pp. 308–311, 2001.
- A. D. Johnson, R. E. Handsaker, S. L. Pulit, M. M. Nizzari, C. J. O'Donnell, and P. I. W. De Bakker, “SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap,” Bioinformatics, vol. 24, no. 24, pp. 2938–2939, 2008.
- J. C. Barrett, D. G. Clayton, P. Concannon et al., “Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes,” Nature Genetics, vol. 41, no. 6, pp. 703–707, 2009.
- I. Pe'er, P. I. W. De Bakker, J. Maller, R. Yelensky, D. Altshuler, and M. J. Daly, “Evaluating and improving power in whole-genome association studies using fixed marker sets,” Nature Genetics, vol. 38, no. 6, pp. 663–667, 2006.
- C. C. A. Spencer, Z. Su, P. Donnelly, and J. Marchini, “Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip,” PLoS Genetics, vol. 5, no. 5, Article ID e1000477, 2009.